Price
No data yet.
Social Signal Score
Company Profile
- Sector
- Financial Services
- Industry
- Asset Management
- Beta
- 0.58
- Country
- US
Quote
Valuation & Ratios
Returns & Efficiency
Valuation
FHLChas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
100-23.08%Social Signal Score
Mentions (8)
- Newszacks.com·5d ago·Neutral
Should You Invest in the Fidelity MSCI Health Care Index ETF (FHLC)? Designed to provide broad exposure to the Healthcare - Broad segment of the equity market, the Fidelity MSCI Health Care Index ETF (FHLC) is a passively managed exchange traded fund launched on October 21, 2013.
View source ↗ - News247wallst.com·23d ago·Neutral
Fidelity's Health Care ETF Holds the Biotechs XLV Skips. Retirees Should Know the Difference Two health care ETFs track the same sector but own very different slices of it, and for retirees building a portfolio, that gap in biotech exposure and concentration could matter more than the nearly identical returns suggest.
View source ↗ - Newsfool.com·27d ago·Positive
Which Healthcare ETF Is the Better Buy: Fidelity's FHLC or State Street's XLV? State Street Health Care Select Sector SPDR ETF focuses exclusively on S&P 500 healthcare components, leading to a highly concentrated portfolio. Fidelity MSCI Health Care Index ETF provides broader industry exposure and reaches deeper into mid-cap and small-cap segments.
View source ↗ - Newsfool.com·42d ago·Positive
Which Healthcare ETF Is the Better Buy: Fidelity’s Broad FHLC or Invesco’s Biotech-Focused PBE? One offers broad diversification at 0.08% cost, while the other targets concentrated biotech growth with higher volatility.
View source ↗ - Newsfool.com·48d ago·Positive
Better Healthcare ETF: Fidelity's Broad, Low-Cost FHLC vs. State Street's XBI Targeting Biotech The Fidelity MSCI Health Care Index ETF offers a significantly lower expense ratio and a more diversified portfolio than the State Street SPDR S&P Biotech ETF. The State Street SPDR S&P Biotech ETF experienced a much deeper maximum drawdown over the last five years but outperformed on a 1-year total return basis.
View source ↗ - Newszacks.com·68d ago·Neutral
Should You Invest in the Fidelity MSCI Health Care Index ETF (FHLC)? Designed to provide broad exposure to the Healthcare - Broad segment of the equity market, the Fidelity MSCI Health Care Index ETF (FHLC) is a passively managed exchange traded fund launched on October 21, 2013.
View source ↗ - Newsetftrends.com·69d ago·Positive
Tackle Market Uncertainty With Strategic Healthcare Exposure With much of the attention in the capital markets directed towards the technology sector, it's easy to forget other sectors like healthcare. However, it's key to consider other sectors within your portfolio to help hedge against heavy volatility.
View source ↗ - Newsfool.com·91d ago·Positive
FHLC vs. PJP: Which Healthcare ETF Is the Better Buy for Investors? Fidelity MSCI Health Care Index ETF (FHLC) offers a significantly lower expense ratio and a higher dividend yield than the Invesco Pharmaceuticals ETF (PJP). PJP provides a concentrated portfolio of just over 30 pharmaceutical stocks, while FHLC diversifies across more than 300 holdings.
View source ↗
Congress trades
- Virginia Ann Foxxhouse · NC05 · disclosed Jan 3, 2023 (301d later)Sell$15,001 - $50,000
- Virginia Ann Foxxhouse · NC05 · disclosed Apr 5, 2022 (393d later)Sell$15,001 - $50,000
- Virginia Ann Foxxhouse · NC05 · disclosed Feb 4, 2022 (32d later)Buy$15,001 - $50,000
- Kevin Hernhouse · OK01 · disclosed Sep 15, 2021 (47d later)Buy$50,001 - $100,000
Self-reported filings, amounts as brackets. Via Senate/House disclosures.
